BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Lung Summit//WCLC26_LungCancerTop10//EN
CALSCALE:GREGORIAN
X-WR-CALNAME:WCLC26_LungCancerTop10
X-WR-CALDESC:Top 10 abstracts at IASLC 2026 World Conference on Lung Cancer
 \, selected by Dr. Mehrpouya Mobin. All times Korea Standard Time.
X-WR-TIMEZONE:Asia/Seoul
BEGIN:VTIMEZONE
TZID:Asia/Seoul
BEGIN:STANDARD
DTSTART:19881009T030000
TZOFFSETFROM:+1000
TZOFFSETTO:+0900
TZNAME:KST
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
UID:wclc2026-pl02-03@lungsummit.org
SEQUENCE:0
DTSTAMP:20260903T194447Z
DTSTART;TZID=Asia/Seoul:20260913T085900
DTEND;TZID=Asia/Seoul:20260913T090900
SUMMARY:PL02.03 Tam-Peli\, an Anti-B7-H3 Antibody-Drug Conjugate\, Versus T
 opotecan in Relapsed SCLC: A Randomized\, Open-Label\, Phase 3 Study
LOCATION:Plenary\, Hall D2\, 3F\, COEX\, Seoul
DESCRIPTION:Tam-Peli\, an Anti-B7-H3 Antibody-Drug Conjugate\, Versus Topot
 ecan in Relapsed SCLC: A Randomized\, Open-Label\, Phase 3 Study\n\nPresen
 ter: Li Zhang\nAbstract: PL02.03\nSession: PL02. Presidential Symposium 1 
 Including Lectureship Award Presentations\nRoom: Plenary\, Hall D2\, 3F\, 
 COEX\, Seoul\nCongress programme: https://cattendee.abstractsonline.com/me
 eting/21487/Presentation/5028\n\nOne of the Top 10 abstracts at IASLC 2026
  World Conference on Lung Cancer\, selected by Dr. Mehrpouya Mobin. More a
 t https://lungsummit.org
URL:https://cattendee.abstractsonline.com/meeting/21487/Presentation/5028
STATUS:CONFIRMED
TRANSP:OPAQUE
END:VEVENT
BEGIN:VEVENT
UID:wclc2026-pl02-04@lungsummit.org
SEQUENCE:0
DTSTAMP:20260903T194447Z
DTSTART;TZID=Asia/Seoul:20260913T091100
DTEND;TZID=Asia/Seoul:20260913T092100
SUMMARY:PL02.04 Risvutatug Rezetecan (a B7-H3-Directed ADC) Versus Topoteca
 n in Relapsed SCLC: Primary Results of Phase 3 ARTEMIS-008
LOCATION:Plenary\, Hall D2\, 3F\, COEX\, Seoul
DESCRIPTION:Risvutatug Rezetecan (a B7-H3-Directed ADC) Versus Topotecan in
  Relapsed SCLC: Primary Results of Phase 3 ARTEMIS-008\n\nPresenter: Jie W
 ang\nAbstract: PL02.04\nSession: PL02. Presidential Symposium 1 Including 
 Lectureship Award Presentations\nRoom: Plenary\, Hall D2\, 3F\, COEX\, Seo
 ul\nCongress programme: https://cattendee.abstractsonline.com/meeting/2148
 7/Presentation/5029\n\nOne of the Top 10 abstracts at IASLC 2026 World Con
 ference on Lung Cancer\, selected by Dr. Mehrpouya Mobin. More at https://
 lungsummit.org
URL:https://cattendee.abstractsonline.com/meeting/21487/Presentation/5029
STATUS:CONFIRMED
TRANSP:OPAQUE
END:VEVENT
BEGIN:VEVENT
UID:wclc2026-pl02-06@lungsummit.org
SEQUENCE:0
DTSTAMP:20260903T194447Z
DTSTART;TZID=Asia/Seoul:20260913T095300
DTEND;TZID=Asia/Seoul:20260913T100300
SUMMARY:PL02.06 Primary Results from Phase 3 EVOKE-03/KEYNOTE D46: Sacituzu
 mab Govitecan + Pembrolizumab in PD-L1 TPS ≥50% Metastatic NSCLC
LOCATION:Plenary\, Hall D2\, 3F\, COEX\, Seoul
DESCRIPTION:Primary Results from Phase 3 EVOKE-03/KEYNOTE D46: Sacituzumab 
 Govitecan + Pembrolizumab in PD-L1 TPS ≥50% Metastatic NSCLC\n\nPresente
 r: Giannis Mountzios\nAbstract: PL02.06\nSession: PL02. Presidential Sympo
 sium 1 Including Lectureship Award Presentations\nRoom: Plenary\, Hall D2
 \, 3F\, COEX\, Seoul\nCongress programme: https://cattendee.abstractsonlin
 e.com/meeting/21487/Presentation/5045\n\nOne of the Top 10 abstracts at IA
 SLC 2026 World Conference on Lung Cancer\, selected by Dr. Mehrpouya Mobin
 . More at https://lungsummit.org
URL:https://cattendee.abstractsonline.com/meeting/21487/Presentation/5045
STATUS:CONFIRMED
TRANSP:OPAQUE
END:VEVENT
BEGIN:VEVENT
UID:wclc2026-oa04-02@lungsummit.org
SEQUENCE:0
DTSTAMP:20260903T194447Z
DTSTART;TZID=Asia/Seoul:20260913T152700
DTEND;TZID=Asia/Seoul:20260913T153700
SUMMARY:OA04.02 Neoadjuvant Durvalumab + Chemotherapy for Resectable/Border
 line Resectable Stage IIB-IIIB NSCLC: MDT-BRIDGE Primary Analysis
LOCATION:Auditorium\, 3F\, COEX\, Seoul
DESCRIPTION:Neoadjuvant Durvalumab + Chemotherapy for Resectable/Borderline
  Resectable Stage IIB-IIIB NSCLC: MDT-BRIDGE Primary Analysis\n\nPresenter
 : Martin Reck\nAbstract: OA04.02\nSession: OA04. Redefining Perioperative 
 Therapy in Resectable NSCLC Integrating Immunotherapy and Molecular Target
 ed Strategies to Improve Cure\nRoom: Auditorium\, 3F\, COEX\, Seoul\nCongr
 ess programme: https://cattendee.abstractsonline.com/meeting/21487/Present
 ation/5042\n\nOne of the Top 10 abstracts at IASLC 2026 World Conference o
 n Lung Cancer\, selected by Dr. Mehrpouya Mobin. More at https://lungsummi
 t.org
URL:https://cattendee.abstractsonline.com/meeting/21487/Presentation/5042
STATUS:CONFIRMED
TRANSP:OPAQUE
END:VEVENT
BEGIN:VEVENT
UID:wclc2026-oa05-01@lungsummit.org
SEQUENCE:0
DTSTAMP:20260903T194447Z
DTSTART;TZID=Asia/Seoul:20260913T164700
DTEND;TZID=Asia/Seoul:20260913T165700
SUMMARY:OA05.01 Tarlatamab Extended-Interval Dosing Regimens in Patients Wi
 th SCLC: The Randomized Phase 2 DeLLphi-309 Study
LOCATION:Room 103\, Grand Ballroom\, 1F\, COEX\, Seoul
DESCRIPTION:Tarlatamab Extended-Interval Dosing Regimens in Patients With S
 CLC: The Randomized Phase 2 DeLLphi-309 Study\n\nPresenter: Jonathan Goldm
 an\nAbstract: OA05.01\nSession: OA05. From Discovery to Practice in SCLC: 
 Redefining Standards of Care and the Next Generation of Targeted Therapies
 \nRoom: Room 103\, Grand Ballroom\, 1F\, COEX\, Seoul\nCongress programme:
  https://cattendee.abstractsonline.com/meeting/21487/Presentation/5041\n\n
 One of the Top 10 abstracts at IASLC 2026 World Conference on Lung Cancer
 \, selected by Dr. Mehrpouya Mobin. More at https://lungsummit.org
URL:https://cattendee.abstractsonline.com/meeting/21487/Presentation/5041
STATUS:CONFIRMED
TRANSP:OPAQUE
END:VEVENT
BEGIN:VEVENT
UID:wclc2026-pl03-01@lungsummit.org
SEQUENCE:0
DTSTAMP:20260903T194447Z
DTSTART;TZID=Asia/Seoul:20260914T081700
DTEND;TZID=Asia/Seoul:20260914T082700
SUMMARY:PL03.01 Adjuvant Osimertinib in Resected EGFR-Mutated Stage IB-IIIA
  NSCLC: ADAURA Exploratory 8-year Overall Survival Landmark Update
LOCATION:Plenary\, Hall D2\, 3F\, COEX\, Seoul
DESCRIPTION:Adjuvant Osimertinib in Resected EGFR-Mutated Stage IB-IIIA NSC
 LC: ADAURA Exploratory 8-year Overall Survival Landmark Update\n\nPresente
 r: Roy Herbst\nAbstract: PL03.01\nSession: PL03. Presidential Symposium 2 
 Including Lectureship Award Presentations\nRoom: Plenary\, Hall D2\, 3F\, 
 COEX\, Seoul\nCongress programme: https://cattendee.abstractsonline.com/me
 eting/21487/Presentation/5036\n\nOne of the Top 10 abstracts at IASLC 2026
  World Conference on Lung Cancer\, selected by Dr. Mehrpouya Mobin. More a
 t https://lungsummit.org
URL:https://cattendee.abstractsonline.com/meeting/21487/Presentation/5036
STATUS:CONFIRMED
TRANSP:OPAQUE
END:VEVENT
BEGIN:VEVENT
UID:wclc2026-pl03-03@lungsummit.org
SEQUENCE:0
DTSTAMP:20260903T194447Z
DTSTART;TZID=Asia/Seoul:20260914T084900
DTEND;TZID=Asia/Seoul:20260914T085900
SUMMARY:PL03.03 First-line Amivantamab-chemotherapy vs Chemotherapy in NSCL
 C with EGFR Exon 20 Insertions: Overall Survival from PAPILLON
LOCATION:Plenary\, Hall D2\, 3F\, COEX\, Seoul
DESCRIPTION:First-line Amivantamab-chemotherapy vs Chemotherapy in NSCLC wi
 th EGFR Exon 20 Insertions: Overall Survival from PAPILLON\n\nPresenter: C
 hul Kim\nAbstract: PL03.03\nSession: PL03. Presidential Symposium 2 Includ
 ing Lectureship Award Presentations\nRoom: Plenary\, Hall D2\, 3F\, COEX\,
  Seoul\nCongress programme: https://cattendee.abstractsonline.com/meeting/
 21487/Presentation/5034\n\nOne of the Top 10 abstracts at IASLC 2026 World
  Conference on Lung Cancer\, selected by Dr. Mehrpouya Mobin. More at http
 s://lungsummit.org
URL:https://cattendee.abstractsonline.com/meeting/21487/Presentation/5034
STATUS:CONFIRMED
TRANSP:OPAQUE
END:VEVENT
BEGIN:VEVENT
UID:wclc2026-pl03-04@lungsummit.org
SEQUENCE:0
DTSTAMP:20260903T194447Z
DTSTART;TZID=Asia/Seoul:20260914T090100
DTEND;TZID=Asia/Seoul:20260914T091100
SUMMARY:PL03.04 Zipalertinib Plus Chemotherapy for 1st Line NSCLC with EGFR
  Exon 20 Insertions: Results From the Phase 3 Trial (REZILIENT 3)
LOCATION:Plenary\, Hall D2\, 3F\, COEX\, Seoul
DESCRIPTION:Zipalertinib Plus Chemotherapy for 1st Line NSCLC with EGFR Exo
 n 20 Insertions: Results From the Phase 3 Trial (REZILIENT 3)\n\nPresenter
 : Daniel Tan\nAbstract: PL03.04\nSession: PL03. Presidential Symposium 2 I
 ncluding Lectureship Award Presentations\nRoom: Plenary\, Hall D2\, 3F\, C
 OEX\, Seoul\nCongress programme: https://cattendee.abstractsonline.com/mee
 ting/21487/Presentation/5108\n\nOne of the Top 10 abstracts at IASLC 2026 
 World Conference on Lung Cancer\, selected by Dr. Mehrpouya Mobin. More at
  https://lungsummit.org
URL:https://cattendee.abstractsonline.com/meeting/21487/Presentation/5108
STATUS:CONFIRMED
TRANSP:OPAQUE
END:VEVENT
BEGIN:VEVENT
UID:wclc2026-pl03-06@lungsummit.org
SEQUENCE:0
DTSTAMP:20260903T194447Z
DTSTART;TZID=Asia/Seoul:20260914T093800
DTEND;TZID=Asia/Seoul:20260914T094800
SUMMARY:PL03.06 Zidesamtinib in TKI-naive Patients with Advanced/Metastatic
  ROS1+ NSCLC: ARROS-1 Efficacy and Safety Data
LOCATION:Plenary\, Hall D2\, 3F\, COEX\, Seoul
DESCRIPTION:Zidesamtinib in TKI-naive Patients with Advanced/Metastatic ROS
 1+ NSCLC: ARROS-1 Efficacy and Safety Data\n\nPresenter: Alexander Drilon
 \nAbstract: PL03.06\nSession: PL03. Presidential Symposium 2 Including Lec
 tureship Award Presentations\nRoom: Plenary\, Hall D2\, 3F\, COEX\, Seoul
 \nCongress programme: https://cattendee.abstractsonline.com/meeting/21487/
 Presentation/5035\n\nOne of the Top 10 abstracts at IASLC 2026 World Confe
 rence on Lung Cancer\, selected by Dr. Mehrpouya Mobin. More at https://lu
 ngsummit.org
URL:https://cattendee.abstractsonline.com/meeting/21487/Presentation/5035
STATUS:CONFIRMED
TRANSP:OPAQUE
END:VEVENT
BEGIN:VEVENT
UID:wclc2026-pl03-08@lungsummit.org
SEQUENCE:0
DTSTAMP:20260903T194447Z
DTSTART;TZID=Asia/Seoul:20260914T101000
DTEND;TZID=Asia/Seoul:20260914T102000
SUMMARY:PL03.08 First-Line Trastuzumab Deruxtecan (T-DXd) in Patients With 
 Metastatic HER2-Mutant NSCLC: DESTINY-Lung04 Primary Results
LOCATION:Plenary\, Hall D2\, 3F\, COEX\, Seoul
DESCRIPTION:First-Line Trastuzumab Deruxtecan (T-DXd) in Patients With Meta
 static HER2-Mutant NSCLC: DESTINY-Lung04 Primary Results\n\nPresenter: Jul
 ia Rotow\nAbstract: PL03.08\nSession: PL03. Presidential Symposium 2 Inclu
 ding Lectureship Award Presentations\nRoom: Plenary\, Hall D2\, 3F\, COEX
 \, Seoul\nCongress programme: https://cattendee.abstractsonline.com/meetin
 g/21487/Presentation/5033\n\nOne of the Top 10 abstracts at IASLC 2026 Wor
 ld Conference on Lung Cancer\, selected by Dr. Mehrpouya Mobin. More at ht
 tps://lungsummit.org
URL:https://cattendee.abstractsonline.com/meeting/21487/Presentation/5033
STATUS:CONFIRMED
TRANSP:OPAQUE
END:VEVENT
END:VCALENDAR